metaMe Health licenses rights to commercialization of Regulora in Canada to Launchit Ventures, Inc. to expedite the availability of Regulora…
Recent research study demonstrates that the majority of clients experience reliable improvement in symptoms after just two months of treatmentVANCOUVER,…
SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging…
- Enhanced performance with increased strength - MicroLead 2.0 With >2x the cross-sectional metal as the original, the MicroLead 2.0…
-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and…
This partnership brings eSight 4 availability to 1,298 VA centers nationwideTORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform,…
ANAHEIM, CA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…
31% increase in branded cannabis net revenue1 to $10.0 million from $7.6 million in the prior year#12 ranking for market…
Hosted Key Opinion Leader (KOL) Symposium; KOLs Presented Positive Updated Batiraxcept Phase 1b Clear Cell Renal Cell Carcinoma (ccRCC) and…
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company…